Skip to main navigation Skip to search Skip to main content

Ischemic cardiac complications following G-CSF

Research output: Contribution to journalArticlepeer-review

Abstract

Granulocyte-colony stimulating factor (G-CSF) is commonly used in bone marrow transplant donors to increase the number of circulating progenitor cells. G-CSF has also been studied following myocardial infarction, but concern has been raised about the risks of G-CSF administration in patients with coronary artery disease. We present two cases of ischemic cardiac complications that are likely to be related to administration of G-CSF and provide a contemporary overview of the literature on the cardiovascular risks of G-CSF.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalCatheterization and Cardiovascular Interventions
Volume76
Issue number1
DOIs
StatePublished - Jul 1 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coronary artery disease
  • Filgrastim/adverse effects
  • Inflammation
  • Myocardial infarction

Fingerprint

Dive into the research topics of 'Ischemic cardiac complications following G-CSF'. Together they form a unique fingerprint.

Cite this